MR

Mabbu Rajeswari

Active Director Designated Partner DIN 08508879
DIN 08508879 First appointment Jul 2019 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Mabbu Rajeswari

Data last updated:

Mabbu Rajeswari is a Designated Partner at Endolap Surgicals India Llp (since 2019). The company operates in Healthcare.

DIN 08508879
Primary Designation Designated Partner
Industry Healthcare
First Appointment 12 Jul 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Jul 20192019Active

Board colleagues of Mabbu Rajeswari

NameDINCompanyDesignation
Premila Honnaiah08495316Endolap Surgicals India LlpDesignated Partner
Siva Parvathi Koduri08503250Endolap Surgicals India LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Endolap Surgicals India Llp
Premium access

Shareholding and investment profile for Mabbu Rajeswari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mabbu Rajeswari

Mabbu Rajeswari currently holds 1 directorship: Endolap Surgicals India Llp (Designated Partner, since 12 Jul 2019).

Mabbu Rajeswari was first appointed on 12 Jul 2019 as Designated Partner at Endolap Surgicals India Llp.

The current boards of Mabbu Rajeswari's companies include Premila Honnaiah (Endolap Surgicals India Llp), Siva Parvathi Koduri (Endolap Surgicals India Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available